442 related articles for article (PubMed ID: 31008670)
1. Efficacy of intratympanic corticosteroid, intravenous batroxobin and combined treatment for sudden sensorineural hearing loss with type-2 diabetes.
Jia H; Yu Z; Li X; Wang J; Ge X; Chen ZT; Huang X; Wei Y
Acta Otolaryngol; 2019 Jun; 139(6):522-528. PubMed ID: 31008670
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of systemic and intratympanic corticosteroid combination therapy versus intratympanic or systemic therapy in patients with idiopathic sudden sensorineural hearing loss: a randomized controlled trial.
Ashtiani MK; Firouzi F; Bastaninejad S; Dabiri S; Nasirmohtaram S; Saeedi N; Ghazavi H; Sahebi L
Eur Arch Otorhinolaryngol; 2018 Jan; 275(1):89-97. PubMed ID: 29149379
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of intratympanic steroid therapy for idiopathic sudden sensorineural hearing loss: comparison with systemic steroid therapy and combined therapy.
Bae SC; Noh HI; Jun BC; Jeon EJ; Seo JH; Park SY; Kim JK; Lee DH; Oh JH; Park SN; Yeo SW
Acta Otolaryngol; 2013 May; 133(5):428-33. PubMed ID: 23356871
[TBL] [Abstract][Full Text] [Related]
4. [A prospective controlled study on the proper time of intratympanic steroid for profound sudden sensorineural hearing loss of total frequency type].
Zhong SX; Zuo WQ; Zhang BY; Qian Y; Lei Y
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Nov; 53(11):806-810. PubMed ID: 30453397
[No Abstract] [Full Text] [Related]
5. Intratympanic versus intravenous corticosteroid treatment for sudden sensorineural hearing loss in diabetic patients: proposed study protocol for a prospective, randomized superiority trial.
Yang W; Li X; Zhong J; Mei X; Liu H; Yang L; Lu L; Hu H
Trials; 2020 Feb; 21(1):135. PubMed ID: 32014060
[TBL] [Abstract][Full Text] [Related]
6. Prognostic predictors of sudden sensorineural hearing loss in defibrinogenation therapy.
Oya R; Horii A; Akazawa H; Osaki Y; Inohara H
Acta Otolaryngol; 2016; 136(3):271-6. PubMed ID: 26573379
[TBL] [Abstract][Full Text] [Related]
7. Intratympanic steroid injection as a first-line therapy in uremia patients with sudden sensorineural hearing loss.
Tsai HT; Hsueh N; Huang CM; Lin HC
Acta Otolaryngol; 2015 Aug; 135(8):786-90. PubMed ID: 25783847
[TBL] [Abstract][Full Text] [Related]
8. Intratympanic methylprednisolone administration promotes the recovery of idiopathic sudden sensorineural hearing loss: a retrospective case-control study.
Jiang K; Li S; Cheng L; Yang J
Acta Otolaryngol; 2018 Nov; 138(11):998-1003. PubMed ID: 30465620
[TBL] [Abstract][Full Text] [Related]
9. Sudden sensorineural hearing loss in children and adolescents: Clinical characteristics and age-related prognosis.
Kim JY; Han JJ; Sunwoo WS; Koo JW; Oh SH; Park MH; Kim YH
Auris Nasus Larynx; 2018 Jun; 45(3):447-455. PubMed ID: 28888426
[TBL] [Abstract][Full Text] [Related]
10. Comparison of intermittent intratympanic steroid injection and near-continual transtympanic steroid perfusion as salvage treatments for sudden sensorineural hearing loss.
Chou YF; Chen PR; Kuo IJ; Yu SH; Wen YH; Wu HP
Laryngoscope; 2013 Sep; 123(9):2264-9. PubMed ID: 23804460
[TBL] [Abstract][Full Text] [Related]
11. Intratympanic steroids for combined treatment of idiopathic sudden hearing loss: when is it too late?
Amarillo E; Navarro A; Hernández-García E; Plaza G
Acta Otolaryngol; 2019 Jul; 139(7):632-635. PubMed ID: 31124732
[No Abstract] [Full Text] [Related]
12. Intratympanic corticosteroid injection as a first-line treatment of the patients with idiopathic sudden sensorineural hearing loss compared to systemic steroid: A systematic review and meta-analysis.
Mirsalehi M; Ghajarzadeh M; Farhadi M; Akbarnejad Z; Ahmadi S; Salem MM
Am J Otolaryngol; 2022; 43(5):103505. PubMed ID: 35714500
[TBL] [Abstract][Full Text] [Related]
13. Sudden Sensorineural Hearing Loss in Children: A Report of 75 Cases.
Qian Y; Zhong S; Hu G; Kang H; Wang L; Lei Y
Otol Neurotol; 2018 Sep; 39(8):1018-1024. PubMed ID: 30063499
[TBL] [Abstract][Full Text] [Related]
14. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
Haynes DS; O'Malley M; Cohen S; Watford K; Labadie RF
Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923
[TBL] [Abstract][Full Text] [Related]
15. Improvement or Recovery From Sudden Sensorineural Hearing Loss With Steroid Therapy Does Not Preclude the Need for MRI to Rule Out Vestibular Schwannoma.
Puccinelli C; Carlson ML
Otol Neurotol; 2019 Jun; 40(5):674-680. PubMed ID: 31083098
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous versus Sequential Intratympanic Steroid Treatment for Severe-to-Profound Sudden Sensorineural Hearing Loss.
Yoo MH; Lim WS; Park JH; Kwon JK; Lee TH; An YH; Kim YJ; Kim JY; Lim HW; Park HJ
Audiol Neurootol; 2016; 21(6):399-405. PubMed ID: 28384627
[TBL] [Abstract][Full Text] [Related]
17. Audiological outcomes in sudden sensorineural hearing loss with presumed inner ear hemorrhage.
Chen K; Wen L; Zong L; Liu M; Sun J; Wu X
Am J Otolaryngol; 2019; 40(2):274-278. PubMed ID: 30473168
[TBL] [Abstract][Full Text] [Related]
18. Comparison of 2 and 4 Intratympanic Steroid Injections in the Treatment of Idiopathic Sudden Sensorineural Hearing Loss.
Suzuki H; Wakasugi T; Kitamura T; Koizumi H; Do BH; Ohbuchi T
Ann Otol Rhinol Laryngol; 2018 Apr; 127(4):235-240. PubMed ID: 29411622
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous versus subsequent intratympanic dexamethasone for idiopathic sudden sensorineural hearing loss.
Park MK; Lee CK; Park KH; Lee JD; Lee CG; Lee BD
Otolaryngol Head Neck Surg; 2011 Dec; 145(6):1016-21. PubMed ID: 21817157
[TBL] [Abstract][Full Text] [Related]
20. The Impact of Intratympanic Steroid Dosage on Hearing Recovery in Sudden Sensorineural Hearing Loss.
Nelson L; Swanson D; Borowiec E; Crossley J; Geng X; Cao X; Kim HJ; Hoa M
Ann Otol Rhinol Laryngol; 2023 Aug; 132(8):879-887. PubMed ID: 35993281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
